A short review on CRP synthesis inhibition in cardiovascular disease
C-reactive Protein (CRP) is synthesized in the liver. Synthesis is stimulated via the IL-1ß/IL6 pathway. CRP activates the complement system via C1q and macrophages via Fcγ receptors. Since elevated CRP plasma levels are associated with increased cardiovascular risk, CRP may play a causal role in ca...
Saved in:
Main Authors: | Myron Zaczkiewicz (Author), Oliver Zimmermann (Author), Jan Torzewski (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C-Reactive Protein in Human Atherogenesis: Facts and Fiction
by: Oliver Zimmermann, et al.
Published: (2014) -
Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Tahmineh Kandelouei, et al.
Published: (2022) -
The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
by: Rui Cheng, et al.
Published: (2023) -
Assessment of serum levels of MMP-8 and hs CRP in chronic periodontitis patients in relation to atherosclerotic cardiovascular disease
by: Zainab J Raheem, et al.
Published: (2014) -
Distribution and association of hs-CRP with cardiovascular risk variables of metabolic syndrome in adolescent learners
by: Megan A. Rensburg, et al.
Published: (2012)